About Us

Innovating multiplex diagnostics for affordable, high-throughput infectious disease detection

Applied BioCode is an in vitro diagnostic (IVD) company that designs, develops, and commercializes multiplex testing products for infectious disease detection. We have combined “digital barcodes” with immuno- and molecular chemistry to create our proprietary bio-inspired Barcoded Magnetic Bead technology (BMB)

We have an active pipeline of products in development, including panels for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers.

Explore Our Products

Applied BioCode Timeline

From ISO 13485 certification to our latest FDA-cleared panel, our milestones reflect a continued commitment to developing multiplex panels for a growing range of clinical and research applications.

2017

About Us

ISO

About Us

BioCode 2500 Analyzer System

2018

About Us

BioCode GPP / NucliSENS easyMAG

FDA 510(k)

2019

About Us

BioCode GPP / MagNA Pure 96

FDA 510(k)

About Us

BioCode RPP/ NucliSENS easyMAG/ MagNA Pure 96

FDA 510(k)

2020

About Us

BioCode SARS-CoV-2

(EUA)

About Us

2021

About Us

BioCode CoV-2 Flu Plus

(EUA)

2022

2023

BioCode Fungal Panel (RUO)

2024

STI + Resistance Panel (RUO)

2025

About Us

BioCode GPP / KingFisher™ Flex

FDA 510(k)

2026

About Us

BioCode RPP / KingFisher™ Flex

FDA 510(k)

Get to know the people behind the milestones

Meet the team

Our Collaborators 

About Us

About Us

About Us

About Us

About Us